- Sun to raise $1.5 billion for M&A; spotlight on Stada, potential biosimilars interest
- Sun and Cipla prepping for Japan generic entry?
- Sun to take Taro private after sweetened buy-out offer
- MSD India head takes emerging market turbulence in stride
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.